Vertex Pharmaceuticals Inc (VRTX) valuation · P/E 30, rev $12.00B
Vertex Pharmaceuticals Inc (VRTX) P/E 30, rev $12.00B.
| Metric | Value |
|---|---|
| P/E | 30 |
| Market cap | $106.87B |
| Revenue | $12.00B |
| P/S | 8.9 |
VRTX valuation FAQ
What is VRTX's P/E ratio?
Vertex Pharmaceuticals Inc (VRTX) trailing P/E is 30 on the latest cached fundamentals snapshot.
What is VRTX's market cap?
Vertex Pharmaceuticals Inc (VRTX) market cap is $106.87B on the latest cached fundamentals snapshot.
What is VRTX's latest revenue?
Latest cached Vertex Pharmaceuticals Inc (VRTX) revenue was $12.00B. Statements: https://lician.com/financials/vrtx
What is VRTX's price-to-sales ratio?
Vertex Pharmaceuticals Inc (VRTX) price-to-sales (P/S) is 8.9, cached market cap $106.87B divided by revenue $12.00B.
How many VRTX valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Vertex Pharmaceuticals Inc (VRTX): P/E, Market cap, Revenue, and P/S.
Where is VRTX valuation listed?
Cached valuation multiples for Vertex Pharmaceuticals Inc (VRTX) are listed at https://lician.com/valuation/vrtx.
Not investment advice. Cached rows, not a live tape.